SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021509
Filing Date
2022-11-03
Accepted
2022-11-03 06:41:09
Documents
59
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q annx-20220930.htm   iXBRL 10-Q 3283916
2 EX-31.1 annx-ex31_1.htm EX-31.1 21805
3 EX-31.2 annx-ex31_2.htm EX-31.2 21257
4 EX-32.1 annx-ex32_1.htm EX-32.1 20592
  Complete submission text file 0000950170-22-021509.txt   8945725

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT annx-20220930_cal.xml EX-101.CAL 45953
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT annx-20220930_def.xml EX-101.DEF 139181
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT annx-20220930_lab.xml EX-101.LAB 377010
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT annx-20220930.xsd EX-101.SCH 41535
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT annx-20220930_pre.xml EX-101.PRE 268027
53 EXTRACTED XBRL INSTANCE DOCUMENT annx-20220930_htm.xml XML 1517720
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39402 | Film No.: 221356057
SIC: 2834 Pharmaceutical Preparations